Flo-Pred approved for asthma

Taro Pharmaceuticals has received FDA approval for Flo-Pred (prednisolone acetate oral suspension), a prescription corticosteroid for the treatment of asthma, certain allergic and dermatologic conditions, and a variety of other indications. Flo-Pred is formulated with the NonSpil liquid drug delivery system which does not require refrigeration or shaking prior to use and will be available in 5mg/5mL and 15mg/5mL dosage strengths.

For more information call (800) 544-1449 or visit www.tarousa.com.